European Shortages Monitoring Platform (ESMP) training session on routine shortage reporting for marketing authorisation holders of centrally authorised products (CAPs), Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 20 Nov

European Shortages Monitoring Platform (ESMP) training session on routine shortage reporting for marketing authorisation holders of centrally authorised products (CAPs), Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 20 November 2024, 10:00 (CET) to 20 November 2024, 12:00 (CET)

European Shortages Monitoring Platform (ESMP) training session on routine shortage reporting for marketing authorisation holders of CAPs, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 20 November 2024, 10:00 (CET) to 20 No

European Shortages Monitoring Platform (ESMP) training session on routine shortage reporting for marketing authorisation holders of CAPs, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 20 November 2024, 10:00 (CET) to 20 November 2024, 12:00 (CET)

Clinical Data Publication (Policy 0070) webinar - Step 2, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 14 November 2024, 15:00 (CET) to 14 November 2024, 16:00 (CET)

Clinical Data Publication (Policy 0070) webinar - Step 2, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 14 November 2024, 15:00 (CET) to 14 November 2024, 16:00 (CET)

Human medicines European public assessment report (EPAR): Pombiliti, cipaglucosidase alfa, Date of authorisation: 20/03/2023, Revision: 1, Status: Authorised

Human medicines European public assessment report (EPAR): Pombiliti, cipaglucosidase alfa, Date of authorisation: 20/03/2023, Revision: 1, Status: Authorised

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.